Sanofi swaps leaders at animal health unit Merial

Sanofi's ($SNY) animal health business Merial has a new leader, as the French drugmaker replaced Jose Barella with Carsten Hellmann, formerly of Chr. Hansen Holding; Barella is leaving to pursue other opportunities, the company said. Release (PDF) | Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.